Home » Topics » Regulatory

Regulatory
RSS

Nastech claims formulations of sildenafil for nasal delivery

Feb. 11, 2000

Improved topical formulations of aciclovir developed at Recordati

Feb. 11, 2000

FDA approves Lotronex for IBS in women

Feb. 10, 2000

Potential new use for imiquimod explored in small clinical study

Feb. 10, 2000

Insulin sensitizer-anorectic combinations disclosed by Takeda for NIDDM

Feb. 10, 2000

Targretin gel formulation granted priority review status

Feb. 9, 2000

Rhinocort Aqua available across U.S. for allergy relief

Feb. 9, 2000

Cephalon's Provigil beneficial in sleep apnea

Feb. 9, 2000

Boehringer Ingelheim seeks approval for combination hypertension treatments

Feb. 8, 2000

Levaquin as the first antimicrobial for CAP caused by resistant S. pneumoniae

Feb. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...